A myriad of studies performed in humans, cell cultures, hiPSC lines carrying familial AD mutations, AD mouse models, and wild-type mice injected with soluble Aβo indicate that neuronal hyperactivity is an early detrimental event in AD pathogenesis. Here, ABO is linked to Alzheimer disease.